LOGOLOGOLOGOLOGO
    • About us
      • What we do
      • Who we are
        • Governance
        • Staff
        • Vacancies
    • Members
      • EuropaBio Members
      • About Membership
    • How we work
      • Healthcare Biotechnology Council
        • Patient BioForum
        • Study – Impact of the EU’s General Pharmaceutical Legislation
      • Industrial Biotechnology Council
        • EFIB
        • Microorganisms
      • National Associations Council
      • SME Platform
      • Biomanufacturing Platform
        • Biotechnology in our Lives
    • Activities
      • 25 Years of Innovation
      • The EU Biotech Act
      • European Biotech Week
      • EU Projects
        • PRIMED Project
        • APROVALS Project
    • News & Events
      • News
      • Events
    • Library
    Become a member
    ✕

    EuropaBio invited industrial biotech SMEs to learn about EU Policy Priorities

    25/04/2021
    NEWS RELEASE

    EuropaBio invited industrial biotech SMEs to learn about EU Policy Priorities

    Brussels, 26 April 2021 – EuropaBio organised an online info session for SMEs within industrial biotechnology to learn about the EU policies and their possible impact to their current business strategies. The event was organised as one of the initiatives under the EuropaBio SME Platform.

    EuropaBio’s Industrial Biotechnology team Agnes Borg and Lucy McMurtry presented to participants an overview of relevant EU policies impacting industrial biotechnology under the European Green Deal including the Farm to Fork and Industrial strategies, Circular Economy Action Plan, and the Taxonomy Regulation. The participants had a chance to learn about opportunities within the Horizon Europe programme. Finally, the impacts of the recently adopted Transparency Regulation on the risk assessment process were explored.

    The event was moderated by Claire Skentelbery, Director General of EuropaBio

    Please click on the links to access the event’s slides and the recording.

    The next online info session will take place June 3, 2021 and will be dedicated to EU Healthcare Biotech Policy Priorities for SMEs. Please register here.

    About the EuropaBio SME Platform

    The SME platform is a community of SMEs across all sectors in Europe, supported through regular online meetings around EU-level topics that impact commercial biotechnology and represented to EU stakeholders.

    Download
    SMEs-event_industrial-policies_sp_finalDownload

    Share
    Communications Team
    Communications Team

    Related posts

    13/02/2026

    The Association of Biopharmaceutical Manufacturers in Latvia (BRAL) joins EuropaBio: Promoting Access to Innovative Therapies

    Read more
    11/02/2026

    Call for tender: EU Biotech and Life Sciences Alliance MEP Group Secretariat services 2026

    Read more
    06/02/2026

    OECD: A comparison of the innovation and regulatory environments for biotechnology and biosolutions across the European Union and the United States

    Read more

    Important links

    • The Association of Biopharmaceutical Manufacturers in Latvia (BRAL) joins EuropaBio: Promoting Access to Innovative Therapies
    • Call for tender: EU Biotech and Life Sciences Alliance MEP Group Secretariat services 2026

    Categories in our Newsroom

    EBIO-white
    EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.
    Contact us
    Extra links
    Members
    Staff
    Privacy policy
    Legal & cookies
    Events
    Newsroom
    Become a member
    Media pack
    © 2026 Europabio. All Rights Reserved. Designed by EYAS
    Become a member

    Vitamin B2

    The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

    Insulin

    Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.

    Detergents

    Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

    Clothes

    Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

    Algal Omega 3

    Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

    Cheese

    Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.